Heart disease after COVID: what the data say
Nature
Saima May Sidik
2022-08-02
https://idp.nature.com/authorize?response_type=cookie&client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-022-02074-3
References
-
Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Nature Med. 28, 583–590 (2022).
-
Xie, Y. & Al-Aly, Z. Lancet Diabetes Endocrinol. 10, 311–321 (2022).
-
Bazdyrev, E. et al. Pharmaceuticals 14, 807 (2021).
-
Boldrini, M., Canoll, P. D. & Klein, R. S. JAMA Psychiatry 78, 682–683 (2021).
-
Ayoubkhani, D. et al. BMJ 372, n693 (2021).
-
Daugherty, S. E. et al. BMJ 373, n1098 (2021).
-
Singh, T. et al. Heart 108, 46–53 (2022).
-
Expert Consensus Decision Pathway. J. Am. Coll. Cardiol. 79, 1717–1756 (2022).
-
The PHOSP-COVID Collaborative Group. Lancet Respir. Med. 10, 761–775 (2022).
-
Taquet, M., Husain, M., Geddes, J. R., Luciano, S. & Harrison, P. J. eClinicalMedicine 39, 101061 (2021).
-
Wang, E. Y. et al. Nature 595, 283–288 (2021).
-
Al-Aly, Z., Bowe, B. & Xie, Y. Nature Med. 28, 1461–1467 (2022).